Stocks
Lineage Cell Therapeutics, Inc.LCTX
AMEXHealthcareBiotechnology$1.55
A clinical-stage biotechnology company focused on developing regenerative cell therapies derived from stem cells to treat degenerative diseases. Its pipeline includes programs targeting conditions such as geographic atrophy and spinal cord injury, areas with significant unmet medical need. Investors...
52W Range: $0.37 – $2.09
Congressional Interest in Lineage Cell Therapeutics, Inc. (LCTX)
No congressional trades have been disclosed for Lineage Cell Therapeutics, Inc. (LCTX) yet. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
0
Unique Politicians
0
Buys
0
Sells
0
Who in Congress Is Trading LCTX?
No congressional trades found for this stock.